IFNB1 and multiple sclerosis: Interestingly, interferon-β (IFN-β) therapy induced PAH in a multiple sclerosis patient with a nonsense ATP13A3 variant (Glu514*) and IFN-β withdrawal improved their PAH symptoms.32